2024-03-29T00:55:18Z
https://tsukuba.repo.nii.ac.jp/oai
oai:tsukuba.repo.nii.ac.jp:00051759
2023-12-05T02:33:54Z
2780:2180
3:62:5587:7238
TAS-118 (S-1 plus leucovorin) versus S-1 in patients with gemcitabine-refractory advanced pancreatic cancer: a randomised, open-label, phase 3 study (GRAPE trial)
兵頭, 一之介
ヒョウドウ, イチノスケ
HYODO, Ichinosuke
Ioka, Tatsuya
Ueno, Makoto
Ueno, Hideki
Park, Joon Oh
Chang, Heung-Moon
Sasahira, Naoki
Kanai, Masashi
Chung, Ik Joo
Ikeda, Masafumi
Nakamori, Shoji
Mizuno, Nobumasa
Omuro, Yasushi
Yamaguchi, Taketo
Hara, Hiroki
Sugimori, Kazuya
Furuse, Junji
Maguchi, Hiroyuki
Furukawa, Masayuki
Fukuzawa, Kengo
Kim, Jun-Suk
Yukisawa, Seigo
Takeuchi, Masahiro
Okusaka, Takuji
Boku, Narikazu
journal article
Elsevier
2019-01
application/pdf
European Journal of Cancer
106
78
88
0959-8049
AA1075407X
https://tsukuba.repo.nii.ac.jp/record/51759/files/EJC_106.pdf
eng
30471651
https://doi.org/10.1016/j.ejca.2018.10.004
(c) 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
open access